In our latest quarterly podcast investment managers Paul Loudon and Lindsay Scott discuss the ground-breaking and often controversial obesity drugs that have been developed by Novo Nordisk and Eli Lilly. They also consider current goings-on in China and share insights from recent research debates.
Energy economist and historian, Peter Tertzakian summarises his thoughts on investing in energy today. The outlook is undoubtedly uncertain but sharing lessons from history and appreciation of the risks, Peter shared his optimism around the change to come, and the investment opportunities.
“Artificial intelligence” and talk of its ground-breaking capabilities have been around for decades. Almost every company talks the talk around generative AI. But which are the companies making genuine advancements with the technology and how is it going to be transformational for their business?
Corporate Japan has long lagged its developed world peers in IT investment. That’s set to change as the country looks to overcome its demographic challenges and boost productivity. For OBIC, this shift in corporate mindset should prove a powerful long-term growth opportunity.
The information in this area of the website is intended for use by Institutional Investors and Consultants only. It is not intended for use by other investors including members of the general public.
By clicking “Yes” you hereby acknowledge, agree and represent to Walter Scott & Partners Limited that you are an Institutional Investor/Consultant and that you have read and understood the Terms and Conditions which apply.
The information contained on this page is not appropriate for, and should not be used or relied upon by, Retail Investors.
By clicking “No” you will be redirected to our Homepage.
Walter Scott & Partners Limited offers a variety of services intended solely for Institutional Clients from certain countries or regions. We do not offer these services outside of these intended countries or regions. Your country of legal residence will determine the services available to you. The information provided does not constitute an offer of or solicitation for purchase or sale of securities or provision of any investment services.